Aleksandar Videnovic Selected Research

fosmetpantotenate

1/2021	Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration.
1/2019	The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksandar Videnovic Research Topics

Disease

14	Parkinson Disease (Parkinson's Disease) 01/2022 - 02/2008
6	Sleepiness 01/2022 - 02/2013
5	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2021 - 01/2019
4	Disorders of Excessive Somnolence (Hypersomnia) 10/2021 - 04/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 02/2019
3	Narcolepsy 10/2021 - 01/2018
3	Synucleinopathies 01/2021 - 01/2018
2	Obstructive Sleep Apnea 10/2021 - 01/2021
2	Sleep Wake Disorders 01/2021 - 04/2017
2	Disease Progression 01/2021 - 01/2021
2	Movement Disorders (Movement Disorder) 01/2021 - 04/2014
2	REM Sleep Behavior Disorder 01/2021 - 01/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 07/2017
2	Fatigue 08/2020 - 09/2017
2	Multiple Sclerosis 08/2020 - 09/2017
2	Edema (Dropsy) 11/2012 - 12/2010
1	Iron Deficiencies 11/2021
1	Idiopathic Hypersomnia 01/2021
1	Chronobiology Disorders (Circadian Rhythm Disorder) 01/2021
1	Kidney Calculi (Kidney Stone) 01/2021
1	Aphasia (Dysphasia) 02/2019
1	Nervous System Diseases (Neurological Disorders) 02/2019
1	Stroke (Strokes) 02/2019
1	Motor Disorders 01/2019
1	Cognitive Dysfunction 04/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Hypoventilation 01/2017
1	Multiple System Atrophy 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 12/2014
1	Chorea (Rheumatic Chorea) 08/2013
1	Hallucinations (Hallucination) 11/2012
1	Hypertension (High Blood Pressure) 12/2010
1	Parkinsonian Disorders (Parkinsonism) 12/2010
1	Dizziness (Lightheadedness) 12/2010
1	Infections 07/2005
1	West Nile Fever 07/2005
1	Hemolysis 07/2005
1	HELLP Syndrome 07/2005
1	Pre-Eclampsia (Preeclampsia) 07/2005
1	Hemorrhage 07/2005

Drug/Important Bio-Agent (IBA)

5	MelatoninIBA 01/2021 - 02/2013
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2018
3	Biological ProductsIBA 01/2021 - 09/2015
2	fosmetpantotenateIBA 01/2021 - 01/2019
2	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 09/2015
2	EnzymesIBA 02/2019 - 07/2005
2	Amantadine (Aman)FDA LinkGeneric 08/2013 - 11/2012
1	Adenosine (Adenocard)FDA LinkGeneric 11/2021
1	solriamfetolIBA 10/2021
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	Inosine FDA Link 01/2021
1	tasimelteonIBA 01/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 11/2020
1	IronIBA 12/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 10/2017
1	SynucleinsIBA 01/2017
1	alpha-SynucleinIBA 09/2015
1	CreatineIBA 01/2015
1	Tetrabenazine (Nitoman)FDA Link 08/2013
1	Antipsychotic Agents (Antipsychotics)IBA 08/2013
1	Modafinil (Provigil)FDA Link 02/2013
1	Caffeine (No Doz)FDA LinkGeneric 02/2013
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2010
1	Isradipine (Dynacirc)FDA LinkGeneric 12/2010
1	1,4-dihydropyridine (dihydropyridine)IBA 12/2010
1	Antiviral Agents (Antivirals)IBA 07/2005

Therapy/Procedure

9	Therapeutics 01/2021 - 09/2015
8	Phototherapy (Light Therapy) 01/2022 - 04/2017
2	Chronotherapy 01/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2021
2	Activities of Daily Living (ADL) 02/2019 - 01/2019
1	Noninvasive Ventilation 01/2017
1	Institutionalization (Institutionalized Persons) 12/2014
1	Drug Tapering 12/2010
1	Deep Brain Stimulation 02/2008